| Symbol | HGZDY |
|---|---|
| Name | HANGZHOU DIAGENS BIOTECHNOLOGY CO. |
| Sector | UNDEFINED |
| Region | Asia |
| Industry | - |
| Address | China Building A, Hangzhou Intelligent Health No. 609 Hongfeng Rd, Donghu St |
| Telephone | +86 4000-680-888 |
| Fax | — |
| — | |
| Website | https://www.diagens.com/?lang=en |
| Incorporation | CN |
| Incorporated On | 2016 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Hong Kong Stock Exchange |
| CIK | 0002128813 |
| Description | Hangzhou Diagens Biotechnology Co Ltd is a China-based company specializing in the development of medical imaging products and services for medical devices. The Company mainly operates through three business segments. The Medical Imaging Software and Medical Devices segment mainly sells medical imaging software and medical devices. The Technology Licensing segment mainly collects licensing fees from customers (currently including digital infrastructure service providers, research institutions, medical technology companies, and medical institutions) for using iMedImage foundation model through iMedMaaS platform. The Analysis and Consulting Services segment mainly provides consulting services to clients (mainly hospitals) based on the test results of chromosome karyotyping analysis. The Companys main products include artificial intelligence (AI) AutoVision. Additional info from OTC: |
No news found.